# A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)

> **NCT00545363** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 716 (actual)

## Conditions studied

- Postmenopausal Osteoporosis

## Interventions

- **DRUG:** Ibandronate

## Key facts

- **NCT ID:** NCT00545363
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 716 (ACTUAL)
- **Last updated:** 2016-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00545363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00545363, "A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00545363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*